
Sign up to save your podcasts
Or


The lingering fear of CT-based screenings delivering false positives has caused many challenges, but that doesn’t mean achieving accurate diagnostic staging with our non-small cell lung cancer patients is impossible. To prove it, Dr. Erin Schenk walks through the steps she takes to determine a patient’s stage of cancer and how it impacts her treatment approach.
Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
By ReachMDThe lingering fear of CT-based screenings delivering false positives has caused many challenges, but that doesn’t mean achieving accurate diagnostic staging with our non-small cell lung cancer patients is impossible. To prove it, Dr. Erin Schenk walks through the steps she takes to determine a patient’s stage of cancer and how it impacts her treatment approach.
Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.